Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial
- Status
- COMPLETED
- Phase
- NA
FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas
- Status
- COMPLETED
- Phase
- PHASE2
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
- Status
- TERMINATED
- Phase
- PHASE2
Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2